Cargando…
Endoscopic Bariatric and Metabolic Therapies for Liver Disease: Mechanisms, Benefits, and Associated Risks
Nonalcoholic fatty liver disease (NAFLD), including advanced-stage nonalcoholic steatohepatitis (NASH), is currently the most common chronic liver disease worldwide and is projected to become the leading indication for liver transplantation (LT). However, there are no effective pharmacological thera...
Autores principales: | Ren, Mengting, Zhou, Xinxin, Lv, Lu, Ji, Feng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9547260/ https://www.ncbi.nlm.nih.gov/pubmed/36304503 http://dx.doi.org/10.14218/JCTH.2021.00448 |
Ejemplares similares
-
Effects of Bariatric Endoscopy on Non-Alcoholic Fatty Liver Disease: A Comprehensive Systematic Review and Meta-Analysis
por: Ren, Mengting, et al.
Publicado: (2022) -
Training in Bariatric and Metabolic Endoscopic Therapies
por: Jirapinyo, Pichamol, et al.
Publicado: (2018) -
Updates in Endoscopic Bariatric and Metabolic Therapies
por: Qureshi, Hammad, et al.
Publicado: (2023) -
Gut microbiome and microbial metabolites in NAFLD and after bariatric surgery: Correlation and causality
por: Xia, Yi, et al.
Publicado: (2022) -
The Effect of Endoscopic Bariatric and Metabolic Therapies on Gastroesophageal Reflux Disease
por: Kim, Su-Young
Publicado: (2021)